Private Equity

Updated:

RV Invest

RV Invest GmbH operates through a distributed-office structure, with registered entities across the United States and Europe. The firm's physical footprint —...

RV Invest logo

RV Invest

RV Invest GmbH operates through a distributed-office structure, with registered entities across the United States and Europe. The firm's physical footprint — spanning Menlo Park, Mountain View, San Francisco, Los Altos, Boston, New York, Los Angeles, Indianapolis, Manchester, Barcelona, and Luxembourg — suggests an operational thesis rooted in proximity to talent clusters and deal flow rather than centralized portfolio management. The European GmbH suffix and Luxembourg presence indicate a vehicle likely structured for cross-border capital deployment, tax efficiency, and access to both US venture ecosystems and European growth-stage opportunities. The firm's investment mandate appears to favor early-stage technology and growth equity, with a geographic emphasis that mirrors the venture-capital corridors of the US West Coast, the Northeast, and select European innovation hubs. The concentration of offices in California's Bay Area implies strong ties to software, deep-tech, and venture-backed company formation. Simultaneously, the Manchester and Barcelona nodes point to European deal-sourcing capabilities in markets where competitive entry valuations often sit below US benchmarks. No public track record of fund commitments versus direct investments is available. Team size and total deployment figures remain undisclosed. The firm's multi-jurisdictional legal structure — combining German corporate registration with operational hubs in the US and Europe — suggests a family office or private investment group managing generational capital through both fund investments and direct co-investments. The Luxembourg office is a common feature among European family offices and asset managers seeking regulated fund structures under UCITS or AIFMD frameworks. RV Invest's structural differentiator lies in its physical decentralization. Rather than aggregating analysts under a single roof, the firm embeds operators across eight US metro areas and three European cities, each positioned to capture locally sourced deal flow. This architecture resembles the hub-and-spoke models employed by select multi-family offices and early-stage platforms, where general partners cultivate proprietary access through geographic concentration.

General information

Firm type

Private Equity

Year founded

2016

Location

Region

Europe

Country

Germany

City

Ravensburg

Corporate office

Banneggstrasse 57, 88214 Ravensburg, Germany

Principals

Aleksei Zeifman

Investment Team

Nicholas H. Vetter

Investment Team

Timo Köhler

Investment Team

Carla Benichou

Investment Team

Lu Zheng

Investment Team

Susanne Schaffert

Investment Team

Patrick Lally

Investment Team

Alexey A. Lugovskoy

Investment Team

Sector focus

BiotechnologyHealthcare Services

Frequently asked questions

Who makes investment decisions at RV Invest?

The investment team is led by Nicholas H. Vetter and Aleksei Zeifman. Vetter brings operational biotech leadership and direct ties to Vetter Pharma, while Zeifman contributed a decade of investing experience from funds including RBV Capital and a corporate venture role at SCOR. The broader team includes senior figures such as former Novartis Oncology President Susanne Schaffert and former OrbiMed and Fortress investor Patrick Lally, indicating collective decision-making rather than a single CIO model.

What is RV Invest’s relationship with Vetter Pharma?

Nicholas H. Vetter, a member of the third generation of the Vetter Pharma family, is part of the RV Invest investment team. Vetter Pharma is a contract development and manufacturing organization that specializes in aseptic filling and packaging of injectable drugs. RV Invest’s strategy does not require portfolio companies to use Vetter Pharma’s services, but the firm’s team has deep knowledge of pharmaceutical manufacturing and commercialization pathways.

Does RV Invest lead rounds in its portfolio companies?

RV Invest participates in early-stage financing rounds, though its website does not disclose whether it acts as lead investor. The firm has been involved in a syndicate that raised a $125 million Series B for Diagonal Therapeutics and an €8 million seed round for Akribion Therapeutics. The firm typically co-invests alongside specialist life sciences funds and crossover investors.

What is the geographic focus of RV Invest’s portfolio?

RV Invest invests across Europe and the United States. Current portfolio companies are based in Germany, Sweden, the United Kingdom, and the US. The firm has a particular concentration in German and Nordic early-stage biotech, consistent with the locations of its founding team and its headquarters in Ravensburg.

What types of therapeutic modalities does RV Invest target?

RV Invest focuses on platform technologies that produce novel therapeutic modalities rather than traditional small-molecule drug development. The portfolio includes agonist antibodies, in vivo cell reprogramming, RNA-guided cell depletion, cell therapy for rare diseases, radiopharmaceuticals, and epigenetic engineering. The firm does not appear to invest in digital health, medical devices, or diagnostics.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Ravensburg Private Equity profiles